Valeo Pharma To Launch Enoxaparin In Canada Early Next Year

Licensing Agreement Signed With Techdow Last Year

 
• By Dean Rudge

Canadian firm Valeo Pharma is looking to make a splash with enoxaparin biosimilars, Redesca and Redesca HP, following approval from Health Canada.

Magnifying Canada on map
Reprots suggest Sandoz has also received approval from Health Canada for a pair of enoxaparin biosimilars • Source: Shutterstock

More from Biosimilars

More from Products